Alnylam’s HELIOS-B Review: Conflicting Insights Analyzed by Lilu Anderson 25.06.2024 Explore conflicting analyst opinions on Alnylam's HELIOS-B data, contrasting efficacy views for vutrisiran in addressing ATTR-CM treatments.
Bicycle Day: Commemorating First LSD Use by Lilu Anderson 24.04.2024 Swiss chemist Albert Hofmann first synthesized LSD in the 1930s. While research eventually halted, the drug is now being decriminalized ...
NRx Pharmaceuticals: $5M Boost for NRX-101 Drug by Mark Eisenberg 12.02.2024 NRx Pharmaceuticals receives a $5 million milestone payment for the development of its drug candidate NRX-101, supporting its progress through ...
The Transformative Power of Virtual Reality Meditation by Lilu Anderson 19.01.2024 Virtual reality-based meditation is offering new hope to Veterans with treatment-resistant depression by providing an immersive and transformative experience. #MentalHealthCare ...